Compare SUPN & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | APLE |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2012 | 2015 |
| Metric | SUPN | APLE |
|---|---|---|
| Price | $45.64 | $11.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $63.25 | $14.17 |
| AVG Volume (30 Days) | 739.6K | ★ 2.5M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 8.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | $681,539,000.00 | ★ $1,418,986,000.00 |
| Revenue This Year | $8.32 | $0.53 |
| Revenue Next Year | $23.36 | $2.22 |
| P/E Ratio | ★ N/A | $15.80 |
| Revenue Growth | ★ 4.54 | 0.57 |
| 52 Week Low | $29.16 | $10.44 |
| 52 Week High | $57.65 | $16.44 |
| Indicator | SUPN | APLE |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 49.38 |
| Support Level | $45.36 | $11.46 |
| Resistance Level | $47.26 | $11.94 |
| Average True Range (ATR) | 1.28 | 0.23 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 44.79 | 41.57 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.